Takeda And Resolve Therapeutics Enter Autoimmune Partnership

Takeda Pharmaceutical Company Limited ("Takeda") andResolve Therapeutics, LLC("Resolve") today jointly announced that they have entered into a partnership to develop compounds for the treatment of lupus (also known as Systemic Lupus Erythematosus, or SLE) and other autoimmune diseases.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news